Hyperfine vs Sensus Healthcare
Sensus Healthcare is the larger business, with $27.5m of revenue in fiscal 2025 against $13.6m for Hyperfine (2.0 times as much). Hyperfine grew faster (5.2% against -34.3%). Sensus Healthcare kept more of each dollar of sales as profit: a net margin of -28.1% against -262.3%.
| Latest fiscal year | HyperfineHYPR, 2025 | Sensus HealthcareSRTS, 2025 |
|---|---|---|
| Revenue | $13.6m | $27.5m |
| Revenue growth | 5.2% | -34.3% |
| Net income | −$35.6m | −$7.7m |
| Operating margin | -273.4% | — |
| Net margin | -262.3% | -28.1% |
| Return on equity | -79.0% | -14.9% |
| Free cash flow | −$29.1m | $332,000 |
| Cash | $35.1m | $22.1m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $300,000 |
| Employees | 102 | 60 |
| Market value | $72.4m | $45.3m |
| Price vs our value range | — | — |
| Moat score | 22 (Weak) | 43 (Weak) |
| Insider trades, 12 months | 0 buys, 8 sales | 21 buys, 0 sales |